The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

0.51%Dividend Yield

Dec 25

$0.96

Dec 24

$1.25

Dec 23

$0.71

Dec 22

$0.75

Dec 21

$0.40

10Y Growth

11.33%

5Y Growth

19.22%

3Y Growth

10.3%

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF is a direct competitor, focusing on similar biotech and pharmaceutical companies, making it a prime alternative for investors interested in the biotech sector.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF tracks a biotechnology index, directly competing with BBH by offering exposure to biotech stocks, but with a different index methodology.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund is another major competitor, targeting the biotech industry with a selection of companies that often overlaps with those in BBH's portfolio.

Virtus Biotech

BBP

Mkt Cap0

Virtus LifeSci Biotech Products ETF focuses specifically on biotech product companies, competing with BBH by targeting a similar niche within the biotech sector.

Virtus Biotech Clinical Trials

BBC

Mkt Cap0

Virtus LifeSci Biotech Clinical Trials ETF offers exposure to companies in clinical trials, presenting a more focused but still competitive angle to BBH's broader biotech scope.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF competes by investing in biotech and genome companies, offering a thematic investment similar to BBH but with a dynamic investment strategy.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF targets healthcare innovation, including biotech, making it a competitor by focusing on a cutting-edge segment of the market similar to BBH.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF is focused on small- and mid-cap biotech and pharmaceutical companies, offering a unique angle but still competing for the same investment dollars as BBH.

Global X Genomics & Biotechnology

GNOM

Mkt Cap0

Global X Genomics & Biotechnology ETF competes by focusing on genomics and biotechnology, offering a niche within the biotech sector that overlaps with BBH's investment focus.

iShares Genomics Immunology and Healthcare

IDNA

Mkt Cap0

iShares Genomics Immunology and Healthcare ETF competes by investing in companies at the forefront of genomics and immunology, presenting a thematic overlap with BBH's biotech focus.

Holdings

Regions

Sectors

About

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.

CEO

Country

United States

ISIN

US92189F7261

Listings

0 Comments

Share your thoughts

FAQ

What is VanEck Biotech stock price today?▼

The current price of BBH is $187.78 USD — it has increased by +0.12% in the past 24 hours. Watch VanEck Biotech stock price performance more closely on the chart.

What is VanEck Biotech stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange VanEck Biotech stocks are traded under the ticker BBH.

Is VanEck Biotech stock price growing?▼

BBH stock has risen by +0.93% compared to the previous week, the month change is a +3.3% rise, over the last year VanEck Biotech has showed a +20.9% increase.

Does VanEck Biotech pay dividends?▼

Yes, BBH dividends are paid annual. The last dividend per share was 0.96 USD. As of today, Dividend Yield (FWD)% is 0.51%.

In which sector is VanEck Biotech located?▼

VanEck Biotech operates in the Other sector.

When did VanEck Biotech complete a stock split?▼

The last stock split for VanEck Biotech was on February 14, 2012 with a ratio of 3:1.